This is a unique opportunity to help shape the future of equine welfare in British racing, both in terms of racing’s overall welfare strategy and in the way that we communicate about horse welfare to a wide range of inside and outside audiences.
Racing’s new Horse Welfare Board has been established to develop and align a cross-industry programme of work around equine welfare and to set welfare priorities for the sport for the next 5- 10 years.
The Horse Welfare Board is looking for an experienced project manager to assist with this complex but potentially ground-breaking work. The successful candidate will have a proven track record managing cross functional projects, bringing together a range of different projects into coherent programmes of work.
If you feel you have the relevant skills and experience, please apply by completing our application form on the following link Application Form. The closing date for applications will be 23 June 2019
Further details are available at this link on the BHA website
After ten horses, mainly from South America, tested positive
for the stimulant synephrine, the FEI has warned competitors to be vigilant for
Synephrine is used as a weight loss aid and is found in plant
in certain parts of the world. The BHA tells us that it is not licensed for human
or veterinary medicines, or any registered homeopathic products in the UK.
The risk of a problem in the UK is small but our advice, as
ever, is to only use products which carry the BETA NOPS logo. If a product does
not carry the logo, ask the manufacturer whether or not the product has been
tested for NOPS/Prohibited Substances. As a reminder, refer to the NTF advice
on avoiding feedstuff contamination here.
The BHA would like to make
Trainers, veterinary surgeons and other industry participants aware of an
international issue regarding injectable omeprazole manufactured by BOVA. The
following announcement from Racing New South Wales reports that a bottle of
Omeprazole 100mg/ml (BOVA Australia) was confirmed to contain testosterone (an
anabolic androgenic steroid):
Omeprazole 100mg/ml (BOVA UK) is
available in the UK and is a compounded prescription-only veterinary medicine
(POM-V). Following discussion with the manufacturer, the BHA can inform industry
participants that the UK product is manufactured at a separate location to the
In light of the international
situation, the BHA is conducting analysis of the UK product to seek assurance
that a similar issue does not appear evident here. We expect results of the
analysis at the end of next week, and will advise trainers of the results as
soon as possible. In the meantime we would advise trainers to be cautious if
using Omeprazole 100mg/ml in racing Thoroughbreds.
The BHA has informed trainers by email of some new Detection Times for misoprostol and xylazine, and an updated Detection Time for dantrolene. These Detection Times will be effective from 1st June 2019.
The BHA Published Detection Times have been updated to
reflect this change, and can be viewed here. Although
the BHA informs the British Equine Veterinary Association of all these changes,
it is worth checking your vet is aware.
Neither Dantrolene nor Misoprostol are licensed for use in
horses in the UK but they may be prescribed for use in horses by a veterinary
surgeon under the Veterinary Medicine Directorate’s Cascade legislation.
and the Direktorium in Germany have both announced the termination of
requirements introduced during the heightened threat of equine flu around
the effective date is tomorrow (Wednesday 8th May.) In Germany the
change is with immediate effect.
Last week we mentioned that the Irish Racehorse Regulatory
Board had announced that from 1st January 2020, all horses racing in Ireland
will be required to be vaccinated with an equine influenza vaccine containing a
Clade 1 representative every six months. For the remainder of this year, horses
must have been vaccinated on or after the 18th January 2019 with a vaccine
containing a Clade 1 equine influenza representative.
The BHA has informed us that talks are taking place between
the three Tripartite countries (Britain, France and Ireland) to see if there is
any prospect of alignment on aspects of the Equine flu protocols across the
For the Randox Health Grand National Meeting all horses must pass a pre-race examination and trot on the day of the race similar to the Cheltenham Festival.
In addition to this; trainers are required to submit to the BHA 45 days of medication records for horses due to run in the Foxhunter, Topham or Grand National Steeple Chases.
Form A covers all medications given in the 35 days prior to 28th March 2019 and any medication with a long-term effect given in the previous six months of the race day. This Form should be emailed to firstname.lastname@example.org .
Form B is to include any medication administered since the completion and submission of Form A (10 days prior to the day of the race). This Form should be presented to the BHA Veterinary Officer at the pre-race examination and trot-up on the day of the race.
Trainers who have a horse which may be described as a “poor mover” or which has an asymmetrical gait”, should identify these horses to the BHA before Monday 25th March 2019.
From 16th March 2019 it will be a standard requirement that all horses running in Ireland must have been vaccinated on or after 18th January 2019 with a vaccine representing Clade 1. Horses vaccinated with the appropriate vaccination on or after 18th January 2019, will not be required to receive a further emergency booster vaccination.
In accordance with the Rules, horses are not qualified to run if they have received a vaccination within the previous 7 days – 6 clear days must elapse between date of vaccination and date of race (e.g., a horse vaccinated on a Friday can run the following Friday). IHRB Veterinary Officers and Assistants will continue to carry out veterinary inspections with increased scrutiny at entrances to racecourse stables on all horses – Trainers and Handlers are advised that if any horse shows any sign of respiratory disease, they will not be allowed to enter racecourse stables or race.